Sight Sciences Inc (SGHT)
5.96
+0.35
(+6.24%)
USD |
NASDAQ |
May 03, 16:00
5.95
-0.01
(-0.17%)
After-Hours: 20:00
Sight Sciences Enterprise Value: 191.14M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 03, 2024 | 191.14M |
May 02, 2024 | 173.79M |
May 01, 2024 | 172.80M |
April 30, 2024 | 170.82M |
April 29, 2024 | 184.20M |
April 26, 2024 | 157.44M |
April 25, 2024 | 150.50M |
April 24, 2024 | 174.29M |
April 23, 2024 | 175.28M |
April 22, 2024 | 161.90M |
April 19, 2024 | 150.01M |
April 18, 2024 | 155.46M |
April 17, 2024 | 162.40M |
April 16, 2024 | 154.96M |
April 15, 2024 | 169.83M |
April 12, 2024 | 183.70M |
April 11, 2024 | 198.07M |
April 10, 2024 | 189.65M |
April 09, 2024 | 196.59M |
April 08, 2024 | 163.39M |
April 05, 2024 | 170.82M |
April 04, 2024 | 172.31M |
April 03, 2024 | 154.96M |
April 02, 2024 | 165.37M |
April 01, 2024 | 158.93M |
Date | Value |
---|---|
March 28, 2024 | 157.44M |
March 27, 2024 | 152.48M |
March 26, 2024 | 145.05M |
March 25, 2024 | 144.56M |
March 22, 2024 | 150.50M |
March 21, 2024 | 150.50M |
March 20, 2024 | 151.00M |
March 19, 2024 | 148.02M |
March 18, 2024 | 129.19M |
March 15, 2024 | 118.29M |
March 14, 2024 | 114.33M |
March 13, 2024 | 112.35M |
March 12, 2024 | 112.35M |
March 11, 2024 | 117.30M |
March 08, 2024 | 137.62M |
March 07, 2024 | 123.74M |
March 06, 2024 | 122.26M |
March 05, 2024 | 120.27M |
March 04, 2024 | 109.03M |
March 01, 2024 | 97.73M |
February 29, 2024 | 93.31M |
February 28, 2024 | 97.73M |
February 27, 2024 | 108.05M |
February 26, 2024 | 115.42M |
February 23, 2024 | 113.45M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-47.88M
Minimum
Oct 26 2023
1.825B
Maximum
Aug 09 2021
398.88M
Average
276.56M
Median
Jul 06 2023
Enterprise Value Benchmarks
Ainos Inc | 10.28M |
OpGen Inc | 13.61M |
Zomedica Corp | 51.79M |
LENSAR Inc | 13.08M |
Eargo Inc (DELISTED) | -- |
Enterprise Value Related Metrics
Net Income (Quarterly) | -10.69M |
Revenue (Quarterly) | 18.75M |
Total Expenses (Quarterly) | 29.86M |
EPS Diluted (Quarterly) | -0.22 |
Gross Profit Margin (Quarterly) | 85.20% |
Profit Margin (Quarterly) | -57.02% |
Earnings Yield | -19.13% |
Normalized Earnings Yield | -19.13 |